| Application no. and date | 12768999.0 (espacenet) (Federated) (European Patent Register), 20120926 | | Patent/reg. no. and date | DK/EP 2760475, 20180704 | | Publication date | 20140806 | | Priority no. and date | US 201161539280 P, 20110926 | | EP pub. no. and date |
EP 2760475 20140806 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/157543 | | Inventor | BOETTCHER, Brian R., Novartis Institutes for BioMedical Research, Inc.
100 Technology Square
Cambridge, MA 02139, US,
CAPLAN, Shari L., Novartis Institutes for BioMedical Research, Inc.
100 Technology Square
Cambridge, MA 02139, US,
DANIELS, Douglas S., Novartis Institutes for BioMedical Research, Inc.
100 Technology Square
Cambridge, MA 02139, US,
HAMAMATSU, Norio, Novartis Institutes for BioMedical Research, Inc.
100 Technology Square
Cambridge, MA 02139, US,
LICHT, Stuart, Novartis Institutes for BioMedical Research, Inc.
100 Technology Square
Cambridge, MA 02139, US,
WELDON, Stephen Craig, Novartis Institutes for BioMedical Research, Inc.
100 Technology Square
Cambridge, MA 02139, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 47/00 (2006.01) | | Title | Fusionsproteiner til behandling af metaboliske lidelser | | Int. application no. | US2012057384 | | Int. publication no. | WO2013049247 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
